Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

Chinese biotechs aim PD-L1 antibody at hepatitis B

Cancer therapies could help boost patient's immune system

Lucid Group welcomes new talent into their 2019 Futures Academy

Lucid welcomed six new graduates into their training programme, The Futures Academy, this week. Launched in 2017, the Futures Academy is now a well-oiled machine, training and developing new talent...

Lucid Group Communications Limited

- PMLiVE

Escaping the spin cycle of sub-optimal launch

“If you want guarantees, buy a washing machine.” Ralph Hasenhuttl’s words as he was unveiled as the new manager of relegation-threatened Southampton FC brought some refreshing everyday logic to a...

- PMLiVE

Blackwood returns as new life sciences minister

Replaces James O’Shaughnessy at DHSC

- PMLiVE

Time running out for ‘no-deal’ Brexit medicines laws

Needs parliament clearance before 29 March

- PMLiVE

Young are being failed by mental health service, says UK report

Just 30% with a mental health condition get NHS treatment

- PMLiVE

Pfizer takeover rumour ignites Amarin shares

Fish oil product shows great promise

- PMLiVE

Relearning launch: Four key dynamics for pharma launches in 2019

Syneos Health examines some of the key trends shaping industry launches in 2019 and beyond

- PMLiVE

Launch like a PRO: the art and science of successful entry to market

‘The set-up and support of the launch team requires at least as much attention as the important launch strategies and initiatives, with structure, processes and culture all requiring careful thought’

- PMLiVE

Changes at Oxford PharmaGenesis, Reynolds-Mackenzie and more

The latest movers in healthcare comms

- PMLiVE

GSK upbeat on its return to oncology market

Zejula signals comeback after four year hiatus

- PMLiVE

NHS facing early exodus of skilled consultants

A better work-life balance was cited as the main reason for early retirement plans

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links